The TRPV1 agonists RTX and capsaicin were obtained from Sigma-Aldrich. The MAPK inhibitor (U-0126) is from Cell Signaling Technology. The PKC inhibitor CGP53353 and GF109203X were purchased from Tocris Bioscience. Ionomycin was obtained from Alomone Labs.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.